How are these new medications improving patient outcomes?
The new medications are designed to target the underlying causes of gynecological conditions more effectively, thereby providing symptom relief and improving overall quality of life. For example, Elagolix and Relugolix offer non-surgical options for managing endometriosis and uterine fibroids, which can significantly improve patient outcomes and reduce the need for invasive procedures.
